How can infectious colitis be distinguished from inflammatory (immune‑mediated) colitis?

Differentiating Infectious from Inflammatory Colitis

The most reliable way to distinguish infectious from inflammatory (IBD) colitis is through histologic identification of chronic architectural changes—specifically crypt distortion, basal plasmacytosis, and crypt branching—which are characteristic of IBD and rarely present in infectious colitis, combined with appropriate microbiological testing to exclude infection. 1, 2

Key Histologic Features That Distinguish IBD from Infectious Colitis

Features Strongly Favoring IBD:

• Basal plasmacytosis (plasma cells between crypt bases and muscularis mucosae) is the strongest predictor of IBD, present in 63% of UC first attacks vs. only 6% of infectious colitis 1, 3
• Crypt architectural distortion with branching (>2 vertical crypt branches per medium-power field) 1, 3, 4
• Crypt atrophy and irregular villous architecture 1
• Paneth cell metaplasia in the left colon 1
• Diffuse, continuous inflammation rather than patchy involvement 1

Features Favoring Infectious Colitis:

• Absence of architectural changes despite active inflammation 1
• Preserved crypt architecture 2
• Acute inflammation without chronic changes 1, 2

Critical caveat: Histology alone is inadequate for identifying bacterial infections, particularly C. difficile, which can mimic IBD histologically 1. Pseudomembranes are present in only 50% of C. difficile cases overall and just 13% in IBD patients with superinfection 1.

Clinical Features to Assess

Timing and Presentation:

• Acute onset (<1 week) with early fever strongly suggests infectious colitis (81% of infectious cases present acutely vs. 44% of IBD) 4
• Insidious onset or presentation >1 week after symptom onset favors IBD (56% of IBD cases) 4
• Prior mild bowel symptoms or absence of early fever in acute-onset cases suggests IBD 4

Epidemiologic Clues:

• Recent travel abroad, gastrointestinal infection, or antibiotic use may trigger IBD onset (62% of non-insidious IBD cases) 4
• Travel abroad appears to increase IBD risk 4

Essential Diagnostic Testing

Microbiological Workup:

• Stool culture and C. difficile testing are mandatory at presentation to exclude infection 1
• Multiplex PCR followed by guided culture on PCR-positive pathogens provides rapid diagnosis while allowing antibiotic susceptibility testing 5
• Testing should be repeated during disease flares, as superinfections trigger flares in established IBD 1
• Note that 21% of IBD patients may have positive microbial findings at presentation 4

Endoscopic Evaluation with Biopsy:

• Flexible sigmoidoscopy with biopsies from multiple sites (at least 2 from terminal ileum, 4 from different colonic segments, and rectum) is essential for diagnosis 2, 6
• Biopsies should be accompanied by full clinical details including symptom duration, endoscopic findings, and medication history 2
• Colonoscopy may be risky in acute severe colitis; sigmoidoscopy is usually sufficient 6

Histologic Timing Considerations:

• Basal plasmacytosis frequency increases with time from symptom onset: 38% at 1-15 days to 89% at 121-300 days 3
• Optimal biopsy timing is at 1 week after presentation, when histologic signs of IBD are maximal (88%) 3, 4
• Early treatment does not prevent appearance of chronic histologic features 3, 4

Algorithmic Approach

Step 1: Clinical Assessment

• Document symptom onset (acute vs. insidious), presence of early fever, travel history, and prior bowel symptoms 4

Step 2: Immediate Testing

• Obtain stool cultures, C. difficile testing, and consider multiplex PCR 1, 5
• Perform flexible sigmoidoscopy with multiple biopsies if diagnosis unclear 2, 6

Step 3: Histologic Interpretation

• If basal plasmacytosis, crypt distortion, or crypt branching present: Strongly favors IBD 1, 3
• If only acute inflammation without architectural changes: Consider infectious colitis, but follow-up biopsy at 1 week may reveal IBD features 3, 4
• If uncertain: Use term "inflammatory bowel disease unclassified" rather than "indeterminate colitis" for biopsy specimens 1

Step 4: Follow-up Strategy

• For uncertain cases, schedule follow-up procedures at 1 and 5 years for diagnostic reconfirmation 1
• Most cases with uncertain initial diagnosis ultimately behave like UC 1

Common Pitfalls to Avoid

• Do not rely on histology alone to exclude bacterial infection, especially C. difficile 1
• Do not perform colonoscopy with bowel preparation in acute severe colitis; sigmoidoscopy is safer 6
• Do not assume negative stool cultures exclude infection (positive in only 40-60% of infectious colitis cases) 6
• Do not overlook CMV superinfection in steroid-refractory IBD patients; use immunohistochemistry or tissue PCR for diagnosis 1, 7
• Do not diagnose "indeterminate colitis" based on preoperative biopsies due to high diagnostic error potential 1